Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Sanofi U.K. Site To Become Science Park
by Alex Scott
July 1, 2013
| A version of this story appeared in
Volume 91, Issue 26
Sanofi has ceased production at its 108-acre pharmaceutical production complex in Dagenham, in East London. The move is in line with the firm’s strategy to reduce manufacturing costs and optimize R&D. Sanofi has secured permission to turn the site into a business, retail, and science center called Business-East Science & Technology Park. Sanofi forecasts that the repurposing will lead to about 2,000 new jobs during the next five years, most of them science-related. Sanofi had manufactured pharmaceuticals at the site since 1934 and until recently employed about 450 people there.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter